Bionova Scientific, an Asahi Kasei boutique commercial-scale biologics contract development and manufacturing organization (CDMO), has licensed ATUM’s proprietary Leap-In Transposase transposon-based gene delivery and its miCHO cell line development technologies. ATUM’s Leap-In Transposase technology can achieve high levels of gene integration, resulting in a large number of cells with the desired gene insertion, precise integration as a single copy into the host cell’s genome, and inte...